2026-02-12T17:22:12-06:00 2025-03-31 042571780 AAFCPAS INC 50 WASHINGTON STREET WESTBOROUGH MA 01581 990 2024-04-01 043266422 ANGIOGENESIS FOUNDATION INC ANGI 6174012779 ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 VINCENT W LI MD MBA TREASURER 6174012779 2026-02-11 1 1 CHARLES J WEBB CPA P01584539 5083669100 2026-02-05 2024 2025-03-06 01:10:19Z WILLIAM W LI MD ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 3105155 0 X WWW.ANGIO.ORG X 1994 MA TO IMPROVE GLOBAL HEALTH BY ADVANCING ANGIOGENESIS-BASED MEDICINE, DIET, AND LIFESTYLE. GOALS: 1) ADVANCE MODERN MEDICINE BY CHAMPIONING A NEW APPROACH TO CONQUERING DISEASE. 2) HELP PEOPLE LEAD LONGER HEALTHIER LIVES. 3) TRANSFORM THE WAY SOCIETY VIEWS HEALTH AND DISEASE THROUGH PUBLIC AWARENESS AND ADVOCACY, AND RESEARCH ON EVIDENCE-BASED DISEASE PREVENTION AND INTERVENTION. 13 11 7 11 0 0 2249417 3018518 12000 11500 33245 66304 6030 8833 2300692 3105155 0 0 0 0 909291 965954 0 0 95780 304739 718433 1214030 1684387 1086662 1420768 1344088 2773217 464675 464574 879413 2308643 X TO IMPROVE GLOBAL HEALTH BY ADVANCING ANGIOGENESIS-BASED MEDICINE, DIET, AND LIFESTYLE. 0 0 649827 BE THE TRUSTED INFORMATION RESOURCE FOR THE PUBLIC ON NEW DEVELOPMENTS IN HEALTH AND DISEASE MANAGEMENT. 369944 ADVANCE THE FIELD OF ANGIOGENESIS, TREATMENTS, AND PREVENTION THROUGH RESEARCH. 243427 8833 PROMOTE INNOVATION, DEVELOPMENT, AND WIDESPREAD ADOPTION OF TRANSFORMATIVE HEALTH SOLUTIONS FOR PREVENTION AND INTERVENTION. 153122 DELIVER OBJECTIVE, UP-TO-DATE INFORMATION TO HEALTHCARE PROFESSIONALS ON EVIDENCE-BASED MEDICAL PRINCIPLES AND PRACTICES. 59047 11500 HELP PATIENTS AROUND THE WORLD BENEFIT FROM ANGIOGENESIS ADVANCES. 212169 11500 1475367 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 17 0 1 7 1 0 0 0 0 0 0 0 0 0 0 0 0 X 13 11 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA X MARIA AUFIERO 6174012779 ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 WILLIAM W LI MD PRESIDENT, MEDICAL DIRECTOR 50.00 X X 279168 0 53529 VINCENT W LI MD MBA COO, SCI DIRECTOR, TREASURER 50.00 X X 232520 0 52143 CHRISTOPHER J BONAR VMD BOARD CHAIRMAN 5.00 X X 0 0 0 SHAWNA C LI DVM BOARD SECRETARY 1.00 X X 0 0 0 NICOLE K FIRESTONE MBA DIRECTOR 1.00 X 0 0 0 LOUIS C HOOK JR MBA DIRECTOR 1.00 X 0 0 0 DAVID EVANS HON DMUS DIRECTOR 1.00 X 0 0 0 DANIEL C RUTZ MPH DIRECTOR 1.00 X 0 0 0 FRANK BURROWS MBA DIRECTOR 1.00 X 0 0 0 BRIAN CAREY DIRECTOR 1.00 X 0 0 0 RACHAEL RAY DIRECTOR 1.00 X 0 0 0 ROBIN L SMITH MD MBA DIRECTOR 1.00 X 0 0 0 ANDREW C VON ESCHENBACH MD DIRECTOR 1.00 X 0 0 0 MARIA AUFIERO DIRECTOR OF OPERATIONS 50.00 X 165000 0 4950 676688 0 110622 3 0 1 0 0 3018518 3018518 IMAGING LICENSE REVENU 611710 11500 11500 11500 66304 66304 OTHER REVENUE 900001 8833 8833 8833 3105155 20333 0 66304 623637 560256 11750 51631 277328 218149 37674 21505 6476 6476 4052 3907 145 54461 54461 34651 29453 1733 3465 107718 102906 903 3909 110622 110622 9085 7011 349 1725 84493 80499 1641 2353 33072 30508 1477 1087 106316 98641 34 7641 37074 34890 300 1884 20926 20926 3503 3503 6056 5476 580 GRANT ADJUSTMENT 129000 129000 MISCELLANEOUS EXPENSES 31001 31001 DUES AND SUBSCRIPTIONS 4916 3112 1804 1684387 1475367 113240 95780 51368 103344 679904 2603662 604900 3348 47700 575 11224 70172 62885 3993 7287 1344088 2773217 210963 217090 253712 247484 464675 464574 X 879413 2308643 879413 2308643 1344088 2773217 1420768 8462 0 X 0 0 0 X 443133 486494 904187 2249417 3018518 7101749 443133 486494 904187 2249417 3018518 7101749 1716080 5385669 259 140 1304 33245 66304 101252 7203001 164338 0.74770 0.66590 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 70172 62885 7287 7287 X X X X X 0 0 0 0 0 0 0 0 0 WILLIAM W LI MD PRESIDENT, MEDICAL DIRECTOR 279168 0 0 0 0 0 8327 0 45202 0 332697 0 0 0 VINCENT W LI MD MBA COO, SCI DIRECTOR, TREASURER 232520 0 0 0 0 0 6941 0 45202 0 284663 0 0 0 MARIA AUFIERO DIRECTOR OF OPERATIONS 165000 0 0 0 0 0 4950 0 0 0 169950 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 BOARD MEMBERS WILLIAM W. LI AND SHAWNA C. LI HAVE A FAMILY RELATIONSHIP. BOARD MEMBERS WILLIAM W. LI AND VINCENT W. LI HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS CAREFULLY REVIEWED BY THE ORGANIZATION'S CHIEF OPERATING OFFICER AND GOVERNING BOARD'S TREASURER FOR ACCURACY AND COMPLETENESS. THE EXECUTIVE COMMITTEE SHALL REVIEW AND APPROVE THE FORM 990 PRIOR TO SUBMISSION AND ENSURES THAT THE FILING IS TIMELY AND IN COMPLIANCE WITH REGULATORY REQUIREMENTS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A STATEMENT OF PRINCIPLES DISTRIBUTED TO ALL DIRECTORS OF THE BOARD AND STAFF. DIRECTORS SHALL AGREE TO THE ORGANIZATION'S WRITTEN CONFLICT OF INTEREST POLICY, AND ASKED TO COMPLETE A DISCLOSURE FORM DESCRIBING RELATIONSHIPS, INTERESTS, OR SITUATIONS WHICH MIGHT RESULT IN OR APPEAR TO BE AN ACTUAL, APPARENT, OR POTENTIAL CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 IN DETERMINING EXECUTIVE COMPENSATION, THE COMPENSATION COMMITTEE CONDUCTS APPROPRIATE DUE DILIGENCE, INCLUDING COLLECTING AND ANALYZING DATA FROM NATIONAL AND LOCAL COMPENSATION SURVEYS FOR COMPARABILITY, SHALL DOCUMENT THE BASIS FOR ITS DETERMINATION, AND MAKES ITS RECOMMENDATION TO THE BOARD OF DIRECTORS. EXECUTIVE COMPENSATION SHALL BE DESIGNED TO ATTRACT AND RETAIN HIGH-CALIBER EXECUTIVES, ENSURE PAY IS FAIR AND EQUITABLE, AND PROVIDE COMPETITIVE COMPENSATION INFORMED BY THE LIMITS AND EXPECTED GROWTH OF FINANCIAL RESOURCES. THE COMPENSATION PACKAGE SHALL BE CONSIDERED AND APPROVED BY DIRECTORS OF THE BOARD WHO ARE UNRELATED TO AND NOT SUBJECT TO THE CONTROL OF DISQUALIFIED PERSONS INVOLVED IN THE COMPENSATION/TRANSACTION. REASONABLE COMPENSATION SHALL BE DETERMINED BASED UPON A MINIMUM OF 12 CRITERIA, INCLUDING THE NATURE OF THE DUTIES EXPECTED OF THE EXECUTIVE; HIS/HER BACKGROUND AND EXPERIENCE; HIS/HER KNOWLEDGE OF THE BUSINESS; THE CURRENT AND PROJECTED SIZE, INCOME AND EARNINGS OF THE BUSINESS; THE CONTRIBUTION HE/SHE IS EXPECTED TO MAKE IN INCREASING THE ORGANIZATION'S INCOME; THE TIME HE/SHE HAS DEVOTED TO THE ORGANIZATION; THE FAVORABLE ECONOMIC CONDITIONS IN THE U.S.; THE TIME OF YEAR THE COMPENSATION IS DETERMINED; THE RELATIONSHIP AND INTENT OF PARTIES; AND THE AMOUNT PAID IN SIMILAR-SIZED BUSINESSES FOR SIMILAR SERVICES IN SIMILAR INDUSTRIES. THIS PROCESS IS USED TO DETERMINE COMPENSATION FOR THE PRESIDENT AND MEDICAL DIRECTOR AND FOR THE CHIEF OPERATING OFFICER AND SCIENTIFIC DIRECTOR. FAIR AND REASONABLE SHALL ALSO DRIVE THE PROCESS IN DETERMINING NON-EXECUTIVE EMPLOYEE COMPENSATION. COMPENSATION SHALL BE LINKED TO EXPERIENCE, SKILL SETS, PERFORMANCE, FUNCTIONAL RESPONSIBILITIES, AND BENCHMARKED WITH COMPENSATION FOR SIMILAR ROLES IN SIMILAR INDUSTRIES USING ANNUAL PUBLISHED SALARY SURVEYS. AFTER EXERCISING DUE DILIGENCE, THE CHIEF OPERATING OFFICER MAKES RECOMMENDATIONS FOR REGULAR STAFF COMPENSATION TO THE PRESIDENT. THE COMPONENTS OF SALARY AND BENEFITS ARE LISTED IN THE EMPLOYMENT PACKAGE AND CONTRACT. THIS PROCESS IS USED TO DETERMINE COMPENSATION FOR ALL NON-EXECUTIVE STAFF. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS REQUIRED DOCUMENTS, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST.